Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Renate Schmelz's publication output changed over time?
ScholarIQpublication output · 2002–2024
Output grew0% over the shown period — from 1 works in 2002 to 1 in 2024.
1
1
2
1
1
1
1
1
1
1
2002200420062015201620172018201920222024
What are the most-cited papers on Renate Schmelz?
ScholarIQmost cited works
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
Stephan Buch, Felix Stickel, Eric Trépo, Michael Way, Alexander Herrmann, Hans Dieter Nischalke, Mario Brosch, Jonas Rosendahl, Thomas Berg, Monika Ridinger, Marcella Rietschel, Andrew McQuillin, Josef Frank, Falk Kiefer, Stefan Schreiber, Wolfgang Lieb, Michael Soyka, Nasser Semmo, Elmar Aigner, Christian Datz, Renate Schmelz, Stefan Brückner, Sebastian Zeißig, Anna-Magdalena Stephan, Norbert Wodarz, Jacques Devière, N. Clumeck, Christoph Sarrazin, Frank Lammert, Thierry Gustot, Pierre Deltenre, Henry Völzke, Markus M. Lerch, Julia Mayerle, Florian Eyer, Clemens Schafmayer, Sven Cichon, Markus M. Nöthen, Michael Nothnagel, David Ellinghaus, Klaus Huse, André Franke, Steffen Zopf, Claus Hellerbrand, Christophe Moreno, Denis Franchimont, Marsha Y. Morgan, Jochen Hampe
S137905309. 2015564 CitationsOPEN ACCESS
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial
Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Michael Vieth, Ulrike von Arnim, Javier Molina‐Infante, Dirk Hartmann, Albert J. Bredenoord, Constanza Ciriza de los Ríos, Stefan Schubert, Stefan Brückner, Ahmed Madisch, Jamal Hayat, Jan Tack, Stephen Attwood, Ralph Müeller, Roland Greinwald, Alain Schoepfer, Alex Straumann, Jan Tack, Tim Vanuytsel, Hubert Louis, Carmen Musala, Stephan Miehlke, Dorothea Frederking, Monther Bajbouj, Christoph Schlag, Simon Nennstiel, Stefan Brückner, Renate Schmelz, Schmelz Heimerl, Anna-Magdalena Stephan, Christiane Fibbe, Niels Liedtke, Jutta Keller, Ulrich Rosien, Sebastian Haag, A Schneider, Dirk Hartmann, Christoph Schmöcker, Hendrik Buchholz, Frank Lammert, Markus Casper, Matthias Reichert, Ahmed Madisch, D. Sommer, Hubert Mönnikes, Miriam Stengel, M. Schmidtmann, Michaela Müller, Alexander J. Eckardt, Till Wehrmann, Stefan Schubert, Peter Armerding, Wolf Peter Hofmann, Thomas Liceni, Ulrike von Arnim, Arne Kandulski, Jochen Weigt, Norbert Börner, A. Lutz-Vorderbrügge, Jörg Albert, Stefan Zeuzem, Irina Blumenstein, Kathrin Sprinzl, Johannes Hausmann, Arjan Bredenoord, Arjan Bredenoord, Marijn J. Warners, Alfredo Lucendo Villarin, Ángel Arias, Maria Ángeles Tejero Bustos, María Jesús Carrillo Ramos, J.M. Gallardo, Rocío Juárez Tosina, Javier Molina‐Infante, José Luis Zamorano, Cecilio Santander Vaquero, Sergio Casabona, Maria T. Perez, Teresa Rodríguez, Constanza Ciriza de los Ríos, Fernando Canga Rodríguez‐Valcárcel, Isabel Castel de Lucas, Antonia Perelló Juan, Mercè Barenys, Carlos Pons, Isabel Pérez‐Martínez, M. Eugenia Lauret, Andrés Castaño García, Esmeralda Rubio, Alex Straumann, Petr Hrúz, Simon Brunner, Jamal Hayat, Andrew Poullis
Gastroenterology. 2019300 CitationsOPEN ACCESS
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
Andreas Stallmach, C. Langbein, Raja Atreya, Tony Bruns, Axel Dignaß, K Ende, Jochen Hampe, Franz Hartmann, Markus F. Neurath, Jochen Maul, J. Preiß, Renate Schmelz, Britta Siegmund, H Schulze, Niels Teich, Ulrike von Arnim, Daniel C. Baumgart, Carsten Schmidt
Alimentary Pharmacology & Therapeutics. 2016164 CitationsOPEN ACCESS
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Pavel Strnad, Stephan Buch, Karim Hamesch, Janett Fischer, Jonas Rosendahl, Renate Schmelz, Stefan Brueckner, Mario Brosch, C.V. Heimes, V Woditsch, David Scholten, Hans Dieter Nischalke, Sabina Janciauskiene, Mattias Mandorfer, Michael Trauner, M. J. Way, Andrew McQuillin, Matthias Reichert, Marcin Krawczyk, Markus Casper, Frank Lammert, Felix Braun, Witigo von Schönfels, Sebastian Hinz, Greta Burmeister, Claus Hellerbrand, Andreas Teufel, Alexandra Feldman, Jörn M. Schattenberg, Heike Bantel, Anita Pathil, Münevver Demir, Johannes Kluwe, Tobias Boettler, Monika Ridinger, Norbert Wodarz, Michael Soyka, Marcella Rietschel, Falk Kiefer, Thomas Weber, Silke Marhenke, Arndt Vogel, Holger Hinrichsen, Ali Canbay, Martin Schlattjan, K Sosnowsky, Christoph Sarrazin, Johann von Felden, Andreas Geier, Pierre Deltenre, Bence Sipos, Clemens Schafmayer, Michael Nothnagel, Elmar Aigner, Christian Datz, Felix Stickel, Marsha Y. Morgan, Jochen Hampe, Thomas Berg, Christian Trautwein
Gut. 2018136 CitationsOPEN ACCESS
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study
Stefan von Delius, Florian Eckel, Stefan Wagenpfeil, Martina Mayr, Konrad Stock, Frank Kullmann, Florian Obermeier, Johannes Erdmann, Renate Schmelz, Stefan Quasthoff, Helmuth Adelsberger, Rainer Bredenkamp, Roland M. Schmid, C. Lersch
Investigational New Drugs. 200690 Citations
Related on ScholarIQ
University Hospital Carl Gustav Carus
Institution
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
Paper
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial
Paper
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
Paper
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Paper
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study
Paper